Corgi CRCL 2x Daily ETF
CIR · ETF
About CIR
- Issuer
- Corgi
- Expense ratio
- 0.45%
- Assets under management
- $570.37K
- Inception
- Jul 7, 2026
- Asset class
- Equity
- Website
- corgifunds.com
CIR key statistics
- Price-earnings ratio
- 0.00
- Average volume
- 1.38K
- Volume
- 602
- Open price
- $27.87
- High today
- $31.39
- Low today
- $30.40
- 52 Week high
- $48.77
- 52 Week low
- $18.53
Corgi CRCL 2x Daily ETF (CIR) at a glance
As of Oct 20, 2026, Corgi CRCL 2x Daily ETF (CIR) shares are priced at $30.96, giving the company a price-to-earnings ratio of 0.00.
Today the fund has traded between $30.40 and $31.39. The current price is 1.9% above the day's low and 1.4% below its high.
Volume so far is 602 shares, below the average of 1.38K shares a day.
Over the past year Corgi CRCL 2x Daily ETF has ranged from $18.53 to $48.77, and now sits 41% of the way up that range.
CIR news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Littelfuse Names Abhi Khandelwal Chief Financial Officer
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.